Stay updated on Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a Locations section with the Alabama site (Birmingham). Updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure footer link.
    Difference
    0.2%
    Check dated 2025-12-24T14:39:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays revision: v3.3.2 and no longer shows v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:15:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice banner. The core study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:28:27.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    No additions or deletions affecting core study details or page purpose were detected.
    Difference
    0.5%
    Check dated 2025-10-27T21:09:27.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:26:01.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Updated the site version from v3.0.2 to v3.1.0, indicating a new release without other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T05:13:58.000Z thumbnail image

Stay in the know with updates to Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page.